Intracytoplasmic sperm Injection in Kenya

Intracytoplasmic Sperm Injection in Kenya

Intracytoplasmic Sperm Injection (ICSI) is a form of assisted reproductive technology (ART) that has been gaining popularity in Kenya over the past few years. ICSI is a procedure used to treat infertility by injecting a single sperm directly into an egg, thereby increasing the chances of fertilization and pregnancy.

Infertility affects a significant portion of the population in Kenya, with an estimated 10-15% of couples struggling to conceive. The prevalence of infertility is due to a combination of factors, including unhealthy lifestyle habits, exposure to environmental toxins, and the increasing prevalence of sexually transmitted infections (STIs). In response to this growing problem, Kenya has seen a significant increase in the number of fertility clinics offering ICSI treatment.

ICSI is a highly specialized procedure that requires expertise and skill on the part of the medical personnel performing the procedure. The process begins with the stimulation of the ovaries to produce multiple eggs, which are then retrieved and fertilized with sperm in a laboratory setting. The fertilized eggs are then monitored for several days to ensure that they are developing normally, and one healthy embryo is then selected for transfer back into the uterus.

How Does Intracytoplasmic Sperm Injection Work

Intracytoplasmic sperm injection (ICSI) is a form of assisted reproductive technology (ART) that involves directly injecting a single sperm into an egg. The ICSI procedure works as follows:

  • Ovarian stimulation: The first step in the ICSI process is to stimulate the woman’s ovaries to produce multiple eggs, which will be used for the procedure. This is typically done through the use of medications that stimulate the ovaries to produce multiple eggs.
  • Egg retrieval: Once the eggs have matured, they are removed from the ovaries through a minimally invasive procedure known as transvaginal ultrasound aspiration. The eggs are then examined for quality and maturity.
  • Sperm preparation: The man’s semen sample is collected and prepared in the laboratory, usually by washing and concentrating the sperm. The best quality sperm are then selected for use in the ICSI procedure.
  • Injection of sperm into egg: A single sperm is then selected and directly injected into the cytoplasm of each egg using a tiny needle. The needle is so fine that it does not damage the egg, and the sperm is carefully placed inside the egg.
  • Fertilization and culture: After the sperm has been injected into the egg, the eggs are placed in an incubator and monitored for fertilization. If fertilization occurs, the resulting embryos are then cultured in the laboratory for several days.
  • Embryo transfer: The healthiest embryos are then selected for transfer back into the woman’s uterus, usually two to five days after the egg retrieval. The embryo transfer is a simple and non-invasive procedure that involves placing the embryos into the uterus through the cervix.
  • Pregnancy: If the embryos implant and begin to grow, the woman will typically have a pregnancy test several weeks later to confirm the pregnancy.

It is important to keep in mind that while ICSI can be an effective form of ART, success rates can vary depending on a number of factors, including the age of the couple, the cause of infertility, and the quality of the sperm and eggs. It is important to discuss all options and considerations with a qualified medical professional before making a decision about treatment.

Intracytoplasmic Sperm Injection Pros

Intracytoplasmic sperm injection (ICSI) is a type of assisted reproductive technology (ART) that has been used to help couples overcome infertility. Here are some of the potential benefits of ICSI:

  1. Increased chances of fertilization: ICSI involves directly injecting a single sperm into an egg, which can increase the chances of fertilization, particularly in cases where the sperm has poor motility or quality.
  2. Higher success rates: ICSI has been shown to have higher success rates compared to traditional in vitro fertilization (IVF), particularly in cases where there is a high level of male infertility.
  3. Ideal for severe male infertility: ICSI is often used as a treatment option for men with low sperm count, poor sperm motility, or abnormal sperm morphology, as it allows for the direct injection of a single sperm into the egg.
  4. No need for high sperm count: With ICSI, only a single sperm is needed for the procedure, making it ideal for men with low sperm counts.
  5. Shorter treatment time: ICSI can often be completed in a shorter time frame compared to traditional IVF, as only a single sperm is needed for each egg.
  6. Lower risk of multiple pregnancies: ICSI reduces the risk of multiple pregnancies compared to traditional IVF, as only a single embryo is usually transferred to the uterus.
  7. Can be used with donated sperm: ICSI can be used with sperm from a donor, making it a viable option for couples or individuals who are unable to use their own sperm.

It is important to keep in mind that while ICSI has been shown to have several potential benefits, the procedure is not without risks, and success rates can vary depending on a number of factors. It is important to discuss all options with a qualified medical professional before making a decision about treatment.

Cost Of Intracytoplasmic Sperm Injection In Kenya

The cost of intracytoplasmic sperm injection (ICSI) in Kenya can vary depending on a number of factors, including the clinic providing the procedure, the type of insurance coverage available, and the specific needs of the patient.

In general, ICSI is considered to be a relatively expensive form of assisted reproductive technology (ART), with costs ranging from around 500,000 to 1,000,000 Kenyan shillings or more, depending on the clinic. Some private insurance plans may cover part or all of the cost of ICSI, while others may not cover ART procedures at all.

It is important to keep in mind that the cost of ICSI can also be influenced by additional expenses, such as the cost of medications, additional tests or procedures, and any complications that may arise during the treatment. Additionally, some patients may need to pay for additional treatments or procedures, such as in vitro fertilization (IVF) or preimplantation genetic diagnosis (PGD), in order to increase their chances of success.

List Of Hospitals That Offer Intracytoplasmic Sperm Injection In Kenya

Intracytoplasmic sperm injection (ICSI) in Kenya: a woman delivers a ICSI assisted baby

Here is a list of some of the hospitals in Kenya that offer intracytoplasmic sperm injection (ICSI) as a form of assisted reproductive technology (ART):

  • Aga Khan University Hospital, Nairobi
  • Nairobi IVF Centre
  • Lancet Laboratories, Nairobi
  • Fertility Solutions Kenya, Nairobi
  • Karen Hospital, Nairobi
  • Gertrude’s Children’s Hospital, Nairobi
  • The Phoenix Medical Center, Nairobi
  • Nairobi Women’s Hospital, Nairobi
  • The Nova IVI Fertility Centre, Nairobi
  • Jaslok Hospital and Research Centre, Nairobi

It is important to note that this list is not exhaustive, and there are other clinics or hospitals in Kenya that offer ICSI as a treatment option. It is advisable to research and gather as much information as possible about each clinic, including the qualifications and experience of the medical professionals providing the treatment, before making a decision about where to undergo ICSI.

 Uptake of ICSI in Kenya

In Kenya, the success rates of ICSI are quite high, with many couples achieving successful pregnancy outcomes. However, as with any medical procedure, there are also some risks associated with ICSI. These include the possibility of multiple pregnancies, which can increase the risk of complications during pregnancy and delivery, as well as the risk of genetic abnormalities in the offspring.

Despite these risks, ICSI remains a highly sought-after treatment option for couples struggling with infertility in Kenya. This is due in part to the growing awareness and understanding of the procedure among the public, as well as the increasing availability of trained medical personnel and advanced technology.

In addition to ICSI, many fertility clinics in Kenya also offer other forms of assisted reproductive technology, including IVF and intrauterine insemination (IUI). These treatments provide a range of options for couples seeking to start a family and are tailored to meet the individual needs and circumstances of each patient.

Another important factor contributing to the popularity of ICSI in Kenya is the cost. Despite being a highly specialized procedure, the cost of ICSI in Kenya is significantly lower than in many other countries. This affordability, combined with the high success rates and availability of trained medical personnel, has made ICSI an attractive option for couples in Kenya.

It is important to note that ICSI is not a guaranteed solution for infertility, and success rates can vary greatly depending on the underlying cause of infertility and the overall health of the patient. As such, it is important for couples to carefully consider all of their options and seek the advice of a qualified medical professional before deciding on a course of treatment.

In conclusion, ICSI is a highly effective form of assisted reproductive technology that has been gaining popularity in Kenya in recent years. With its high success rates, affordability, and availability of trained medical personnel, ICSI is a promising option for couples struggling with infertility. However, it is important to carefully consider all options and seek the advice of a qualified medical professional before embarking on any form of fertility treatment.

Citations / References:


  • Alukal, Joseph P., and Dolores J. Lamb. “Intracytoplasmic sperm injection (ICSI)–what are the risks?.” Urologic Clinics of North America 35.2 (2008): 277-288.
  • Neri, Queenie V., et al. “Understanding fertilization through intracytoplasmic sperm injection (ICSI).” Cell calcium 55.1 (2014): 24-37.
  • ESHRE Capri Workshop Group. “Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution.” Human reproduction update 13.6 (2007): 515-526.
  • Cox, Gerald F., et al. “Intracytoplasmic sperm injection may increase the risk of imprinting defects.” The American Journal of Human Genetics 71.1 (2002): 162-164.
  • Nagy, Z. P., et al. “Andrology: The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters.” Human reproduction 10.5 (1995): 1123-1129.
  • Murage, Alfred, Murwa C. Muteshi, and Francis Githae. “Assisted reproduction services provision in a developing country: time to act?.” Fertility and sterility 96.4 (2011): 966-968.
  • Wanyoike-Gichuhi, J., et al. “Successful IVF-ICSI with live baby in an azoospermic patient with cryopreserved sperms: Case report.” East African Medical Journal 93.1 (2016): 40-42.
  • Noreh, L. J., et al. “Outcomes of assisted reproductive technologies at the Nairobi In Vitro Fertilisation Centre.” East African Medical Journal 86.4 (2009).